Product Code: ETC13370041 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 | |
According to 6Wresearch internal database and industry insights, the Global Vaccine Market was valued at USD 68.7 Billion in 2024 and is expected to reach USD 110.5 Billion by 2031, growing at a compound annual growth rate of 5.70% during the forecast period (2025-2031).
Global Vaccine Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Vaccine Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Global Vaccine Market - Industry Life Cycle |
3.4 Global Vaccine Market - Porter's Five Forces |
3.5 Global Vaccine Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Global Vaccine Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.8 Global Vaccine Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
3.9 Global Vaccine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.10 Global Vaccine Market Revenues & Volume Share, By Technology, 2021 & 2031F |
4 Global Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Vaccine Market Trends |
6 Global Vaccine Market, 2021 - 2031 |
6.1 Global Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Vaccine Market, Revenues & Volume, By Preventive Vaccines, 2021 - 2031 |
6.1.3 Global Vaccine Market, Revenues & Volume, By Therapeutic Vaccines, 2021 - 2031 |
6.1.4 Global Vaccine Market, Revenues & Volume, By DNA Vaccines, 2021 - 2031 |
6.2 Global Vaccine Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Vaccine Market, Revenues & Volume, By Influenza, 2021 - 2031 |
6.2.3 Global Vaccine Market, Revenues & Volume, By COVID19, 2021 - 2031 |
6.2.4 Global Vaccine Market, Revenues & Volume, By Hepatitis B, 2021 - 2031 |
6.3 Global Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Vaccine Market, Revenues & Volume, By Pediatrics, 2021 - 2031 |
6.3.3 Global Vaccine Market, Revenues & Volume, By Adults, 2021 - 2031 |
6.3.4 Global Vaccine Market, Revenues & Volume, By Geriatrics, 2021 - 2031 |
6.4 Global Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Vaccine Market, Revenues & Volume, By Intramuscular, 2021 - 2031 |
6.4.3 Global Vaccine Market, Revenues & Volume, By Subcutaneous, 2021 - 2031 |
6.4.4 Global Vaccine Market, Revenues & Volume, By Oral, 2021 - 2031 |
6.5 Global Vaccine Market, Revenues & Volume, By Technology, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 Global Vaccine Market, Revenues & Volume, By mRNAbased, 2021 - 2031 |
6.5.3 Global Vaccine Market, Revenues & Volume, By Viral Vector, 2021 - 2031 |
6.5.4 Global Vaccine Market, Revenues & Volume, By Protein Subunit, 2021 - 2031 |
7 North America Vaccine Market, Overview & Analysis |
7.1 North America Vaccine Market Revenues & Volume, 2021 - 2031 |
7.2 North America Vaccine Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Vaccine Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Vaccine Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Vaccine Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
7.4 North America Vaccine Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
7.5 North America Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
7.6 North America Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.7 North America Vaccine Market, Revenues & Volume, By Technology, 2021 - 2031 |
8 Latin America (LATAM) Vaccine Market, Overview & Analysis |
8.1 Latin America (LATAM) Vaccine Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Vaccine Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Vaccine Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Vaccine Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Vaccine Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Vaccine Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
8.4 Latin America (LATAM) Vaccine Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
8.5 Latin America (LATAM) Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
8.6 Latin America (LATAM) Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
8.7 Latin America (LATAM) Vaccine Market, Revenues & Volume, By Technology, 2021 - 2031 |
9 Asia Vaccine Market, Overview & Analysis |
9.1 Asia Vaccine Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Vaccine Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Vaccine Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Vaccine Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Vaccine Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Vaccine Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
9.4 Asia Vaccine Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
9.5 Asia Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
9.6 Asia Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
9.7 Asia Vaccine Market, Revenues & Volume, By Technology, 2021 - 2031 |
10 Africa Vaccine Market, Overview & Analysis |
10.1 Africa Vaccine Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Vaccine Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Vaccine Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Vaccine Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Vaccine Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Vaccine Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
10.4 Africa Vaccine Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
10.5 Africa Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
10.6 Africa Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
10.7 Africa Vaccine Market, Revenues & Volume, By Technology, 2021 - 2031 |
11 Europe Vaccine Market, Overview & Analysis |
11.1 Europe Vaccine Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Vaccine Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Vaccine Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Vaccine Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Vaccine Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Vaccine Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
11.4 Europe Vaccine Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
11.5 Europe Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
11.6 Europe Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
11.7 Europe Vaccine Market, Revenues & Volume, By Technology, 2021 - 2031 |
12 Middle East Vaccine Market, Overview & Analysis |
12.1 Middle East Vaccine Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Vaccine Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Vaccine Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Vaccine Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Vaccine Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
12.4 Middle East Vaccine Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
12.5 Middle East Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
12.6 Middle East Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
12.7 Middle East Vaccine Market, Revenues & Volume, By Technology, 2021 - 2031 |
13 Global Vaccine Market Key Performance Indicators |
14 Global Vaccine Market - Export/Import By Countries Assessment |
15 Global Vaccine Market - Opportunity Assessment |
15.1 Global Vaccine Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F |
15.3 Global Vaccine Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
15.4 Global Vaccine Market Opportunity Assessment, By Age Group, 2021 & 2031F |
15.5 Global Vaccine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
15.6 Global Vaccine Market Opportunity Assessment, By Technology, 2021 & 2031F |
16 Global Vaccine Market - Competitive Landscape |
16.1 Global Vaccine Market Revenue Share, By Companies, 2024 |
16.2 Global Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |